chartexchange

Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026

GlobeNewswire Inc. | Oct 19, 2026 4:05 PM EDT

Features FORTIFY, the ongoing Phase 1b indication expansion trial of PLN-101095 enrolling patients with ICI-refractory solid tumors

Read original article